Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years

BACKGROUND: The present study aimed to evaluate the persistent immunogenicity offered by a third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) residents. METHODS: In this monocenter prospective observational study, anti-spike IgG levels, S1 domain reactive T cell counts,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alidjinou, Enagnon Kazali, Demaret, Julie, Corroyer-Simovic, Bénédicte, Labreuche, Julien, Goffard, Anne, Trauet, Jacques, Lupau, Daniela, Miczek, Sophie, Vuotto, Fanny, Dendooven, Arnaud, Huvent-Grelle, Dominique, Podvin, Juliette, Dreuil, Daniel, Faure, Karine, Deplanque, Dominique, Bocket, Laurence, Duhamel, Alain, Sobaszek, Annie, Hober, Didier, Hisbergues, Michael, Puisieux, Francois, Autran, Brigitte, Yazdanpanah, Yazdan, Labalette, Myriam, Lefèvre, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022478/
https://www.ncbi.nlm.nih.gov/pubmed/35469147
http://dx.doi.org/10.1016/j.lanepe.2022.100385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022478/
https://www.ncbi.nlm.nih.gov/pubmed/35469147
http://dx.doi.org/10.1016/j.lanepe.2022.100385

Ejemplares similares